ZNTL — Zentalis Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSucker Stock

Annual balance sheet for Zentalis Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	67.2	339	340	437	483
Net Total Accounts Receivable
Net Total Receivables	0.14	0.417	0.004	6.38	3.34
Prepaid Expenses
Total Other Current Assets
Total Current Assets	68.9	345	351	452	497
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.84	3.62	52.8	50.1	41.7
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	87.5	366	455	539	552
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	14.9	28.6	43.9	56.6	69.4
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	25.9	57	90.6	106	114
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	61.6	309	364	434	437
Total Liabilities & Shareholders' Equity	87.5	366	455	539	552
Total Common Shares Outstanding